Norris Medicines Ltd

BSE
NORRIS •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or open an account for live prices.
Start SIP in Norris Medicines Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
47.62% Fall from 52W High
2.9
TTM PE Ratio
Negative PE TTM
-12.1
Price to Book Ratio
Negative Price to Book
-1.1
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is negative
-0.4
RSI
RSI is mid-range
67.4
MFI
MFI is mid-range
55.5

Norris Medicines Ltd shareholding Pattern

Promoter
34%
Public
65.9%
Promoter
34%
Public
65.9%
Promoter
34%
Public
65.9%
Promoter
34%
Public
65.9%
Promoter
34%
Public
65.9%
Promoter
34%
Public
65.9%

Norris Medicines Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
13
Bearish Moving Averages
3
5Day EMA
14.40
10Day EMA
14.00
12Day EMA
13.80
20Day EMA
13.30
26Day EMA
13.10
50Day EMA
13.00
100Day EMA
13.70
200Day EMA
13.90
5Day SMA
14.60
10Day SMA
14.10
20Day SMA
12.90
30Day SMA
12.50
50Day SMA
12.30
100Day SMA
14.40
150Day SMA
15.30
200Day SMA
14.40
Delivery & Volume
Resistance & Support
14.41
Pivot
Resistance
First Resistance
14.41
Second Resistance
14.41
Third Resistance
14.41
Support
First Support
14.41
Second support
14.41
Third Support
14.41
Relative Strength Index
67.41
Money Flow Index
55.49
MACD
0.72
MACD Signal
0.47
Average True Range
0.41
Average Directional Index
32.36
Rate of Change (21)
27.52
Rate of Change (125)
-7.03
Peer comparison
Compare
Company
Market Price
Market Cap
52W Low
52W High
Ortin Laboratories Ltd.
16.18
16.15
26.39
Bacil Pharma Ltd.
-
-
-
Beryl Drugs Ltd.
-
-
-
Unjha Formulations Ltd.
-
-
-
Ganga Pharmaceuticals Ltd.
-
-
-
Norris Medicines Ltd.
-
-
-
Parmax Pharma Ltd.
-
-
-

Norris Medicines Ltd Company background

Founded in: 1990
Managing director: Vimal D Shah
Norris Medicines Ltd was established in September, 1990 as a small scale unit at GIDC Estate, Ankleshwar to manufacture non sterile dosage e.g. tablets, capsules, Liquid Orals, Copical ointments. The Company was subsequently converted into Public Limited Company on 7th March 1992. The unit expanded to manufacture Sterile dosage in form of Ampoules Vials. The Company got into the business in the year 1990. Commercial production of the formulation unit commenced in Nov.91. The project commence in March 1992. Thereafter, the Company came out with a Public Issue aggregating Rs 5 cr in Dec.93 to expand its existing capacity for tablets, capsules, etc, besides diversifying into bulk drugs and setting up an injectables unit. The project costing Rs 14.21 Crore was financed through loans and equity, which got completed in 1995.In 2006, the Company launched Diabetic Cardiac products launched Dental product in 2007 launched New Molecule Tolperisone with Paracetamol tablet in 2012 in 2013, it extended Anti malarial range with Artemether Lumefantrine tablet dry syrup. During the year 201314, the Company undertook the upgradation of Sterile Injectable Plant. The Company is one of the leading Indian manufacturers of Injections and Medicinal formulations. The Company is engaged into Health Care Industry and has 2 plants situated at GIDC, Ankleshwar, Gujarat. Both plants of the Company are WHO cGMP approved. At present, it has renovated the Sterile Injectable Plant, which is as per international standards.
Read More

Norris Medicines Ltd FAQs

The Mutual Fund Shareholding was 0.01% at the end of .

You can easily buy Norris Medicines Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -